GB0725103D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0725103D0 GB0725103D0 GBGB0725103.6A GB0725103A GB0725103D0 GB 0725103 D0 GB0725103 D0 GB 0725103D0 GB 0725103 A GB0725103 A GB 0725103A GB 0725103 D0 GB0725103 D0 GB 0725103D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0725103.6A GB0725103D0 (en) | 2007-12-21 | 2007-12-21 | Novel compounds |
| PCT/EP2008/067823 WO2009080682A1 (en) | 2007-12-21 | 2008-12-18 | Pyrrolo[2,3-d]pyrimidine derivatives as cgrp receptor antagonists |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0725103.6A GB0725103D0 (en) | 2007-12-21 | 2007-12-21 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0725103D0 true GB0725103D0 (en) | 2008-01-30 |
Family
ID=39048653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0725103.6A Ceased GB0725103D0 (en) | 2007-12-21 | 2007-12-21 | Novel compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0725103D0 (en) |
| WO (1) | WO2009080682A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201004311D0 (en) | 2010-03-15 | 2010-04-28 | Proximagen Ltd | New enzyme inhibitor compounds |
| DE102011008352A1 (en) | 2011-01-12 | 2012-07-12 | Merck Patent Gmbh | 5 - ([1,2,3] triazol-4-yl) -7H-pyrrolo [2,3-d] pyrimidine derivatives |
| HUE055505T2 (en) * | 2011-05-20 | 2021-11-29 | H Lundbeck As | Anti-CGRP preparations and their use |
| GB201115853D0 (en) | 2011-09-14 | 2011-10-26 | Proximagen Ltd | New enzyme inhibitor compounds |
| SG11201400277VA (en) | 2011-09-14 | 2014-05-29 | Proximagen Ltd | New enzyme inhibitor compounds |
| AU2013312477B2 (en) | 2012-09-06 | 2018-05-31 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| BR112015007513A2 (en) * | 2012-10-26 | 2017-07-04 | Hoffmann La Roche | bruton tyrosine kinase inhibitors |
| US10093683B2 (en) | 2014-04-22 | 2018-10-09 | Merck Sharp & Dohme Corp. | Factor XIa inhibitors |
| AU2015345054B2 (en) | 2014-11-14 | 2020-03-05 | Nerviano Medical Sciences S.R.L. | 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors |
| FR3030521B1 (en) * | 2014-12-23 | 2019-07-26 | Galderma Research & Development | NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE IN MEDICINE AND COSMETICS |
| GB201908420D0 (en) * | 2019-06-12 | 2019-07-24 | Heptares Therapeutics Ltd | Cgrp antagonist compounds |
| GB201908430D0 (en) | 2019-06-12 | 2019-07-24 | Heptares Therapeutics Ltd | Cgrp antagonist compounds |
| US20210128724A1 (en) * | 2019-07-05 | 2021-05-06 | Allergan Pharmaceuticals International Limited | Cgrp antagonists and clostridial derivatives for the treatment of cortical spreading depression associated disorders |
| CN113527308B (en) * | 2021-06-28 | 2022-10-14 | 上海应用技术大学 | A kind of method that utilizes iron complex to catalyze and synthesize 7-deazapurine compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0517418A (en) * | 2004-10-13 | 2008-10-07 | Merck & Co Inc | compound, pharmaceutical composition, and methods for antagonizing cgrp receptor activity in a mammal to treat, control, ameliorate or reduce the risk of headache, migraine or headache, and treating or preventing migraine headaches. , headaches, and headaches |
-
2007
- 2007-12-21 GB GBGB0725103.6A patent/GB0725103D0/en not_active Ceased
-
2008
- 2008-12-18 WO PCT/EP2008/067823 patent/WO2009080682A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009080682A1 (en) | 2009-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0710528D0 (en) | Novel compounds | |
| EP2146745A4 (en) | Novel compounds | |
| EP2152081A4 (en) | Novel compounds | |
| GB0712888D0 (en) | Novel compounds | |
| GB0705882D0 (en) | Novel compounds | |
| GB0710865D0 (en) | Novel compounds | |
| GB0725103D0 (en) | Novel compounds | |
| GB0705803D0 (en) | Novel compounds | |
| GB0708858D0 (en) | Novel compounds | |
| GB0710863D0 (en) | Novel compounds | |
| GB0711521D0 (en) | Novel compounds | |
| GB0712392D0 (en) | Novel compounds | |
| GB0703973D0 (en) | Novel compounds | |
| GB0700078D0 (en) | Novel compounds | |
| GB0703631D0 (en) | Novel compounds | |
| GB0701638D0 (en) | Novel compounds | |
| GB0700996D0 (en) | Novel compounds | |
| GB0700993D0 (en) | Novel compounds | |
| GB0700992D0 (en) | Novel compounds | |
| GB0708747D0 (en) | Novel compounds | |
| GB0700991D0 (en) | Novel compounds | |
| GB0708223D0 (en) | Novel compounds | |
| GB0700363D0 (en) | Novel compounds | |
| GB0706206D0 (en) | Novel compounds | |
| GB0700077D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |